8-85107306-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000360375.8(LRRCC1):c.11C>T(p.Ala4Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,611,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000360375.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRCC1 | NM_033402.5 | c.11C>T | p.Ala4Val | missense_variant | 1/19 | ENST00000360375.8 | NP_208325.3 | |
LOC105375933 | XR_929117.3 | n.304+253G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRCC1 | ENST00000360375.8 | c.11C>T | p.Ala4Val | missense_variant | 1/19 | 1 | NM_033402.5 | ENSP00000353538 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000158 AC: 38AN: 239940Hom.: 0 AF XY: 0.000145 AC XY: 19AN XY: 131194
GnomAD4 exome AF: 0.000260 AC: 380AN: 1458912Hom.: 0 Cov.: 30 AF XY: 0.000270 AC XY: 196AN XY: 725664
GnomAD4 genome AF: 0.000118 AC: 18AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.11C>T (p.A4V) alteration is located in exon 1 (coding exon 1) of the LRRCC1 gene. This alteration results from a C to T substitution at nucleotide position 11, causing the alanine (A) at amino acid position 4 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at